91 related articles for article (PubMed ID: 8646484)
1. High cellular concentration of peripheral blood progenitor cells during cryopreservation adversely affects CFU-GM but not hematopoietic recovery.
Keung YK; Cobos E; Morgan D; Park M; Dixon S; Wu K; Park CH
J Hematother; 1996 Feb; 5(1):73-7. PubMed ID: 8646484
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
[TBL] [Abstract][Full Text] [Related]
3. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors.
Almici C; Ferremi P; Lanfranchi A; Ferrari E; Verardi R; Marini M; Rossi G
Haematologica; 2003 Dec; 88(12):1390-5. PubMed ID: 14687993
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-term storage at -90 degrees C of bone marrow and PBPC on cell recovery, viability, and clonogenic potential.
Ayello J; Semidei-Pomales M; Preti R; Hesdorffer C; Reiss RF
J Hematother; 1998 Aug; 7(4):385-90. PubMed ID: 9735870
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cryopreserved murine and human hematopoietic stem and progenitor cells designated for transplantation.
Balint B; Ivanović Z; Petakov M; Taseski J; Vojvodić D; Jovcić G; Bugarski D; Marjanović S; Malesević M; Stojanović N
Vojnosanit Pregl; 1999; 56(6):577-85. PubMed ID: 10707606
[TBL] [Abstract][Full Text] [Related]
6. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
Sautois B; Fraipont V; Baudoux E; Fassotte MF; Hermanne JP; Jérusalem G; Bours V; Bosquée L; Schaaf-Lafontaine N; Paulus JM; Sondag D; Fillet G; Beguin Y
Haematologica; 1999 Apr; 84(4):342-9. PubMed ID: 10190949
[TBL] [Abstract][Full Text] [Related]
8. CD34+ selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4 degrees C does not affect outcome.
Lazarus HM; Pecora AL; Shea TC; Koç ON; White JM; Gabriel DA; Cooper BW; Gerson SL; Krieger M; Sing AP
Bone Marrow Transplant; 2000 Mar; 25(5):559-66. PubMed ID: 10713636
[TBL] [Abstract][Full Text] [Related]
9. The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy.
Elias AD; Ayash L; Tepler I; Wheeler C; Schwartz G; Mazanet R; Schnipper L; Frei E; Antman K
J Hematother; 1993; 2(3):377-82. PubMed ID: 7522891
[TBL] [Abstract][Full Text] [Related]
10. Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection.
Vanásek J; Filip S; Medková V; Bláha M; Mericka P; Volenec K
Bone Marrow Transplant; 1998 Jan; 21(2):123-6. PubMed ID: 9489627
[TBL] [Abstract][Full Text] [Related]
11. Cryopreservation and mycophenolate therapy are detrimental to hematopoietic progenitor cells.
Bühler L; Kurilla-Mahon B; Chang Q; Abraham S; Alwayn IP; Appel JZ; Newman D; Awwad M; White-Scharf ME; Sackstein R; Sachs DH; Cooper DK; Down JD
Transplantation; 2002 Oct; 74(8):1159-66. PubMed ID: 12438964
[TBL] [Abstract][Full Text] [Related]
12. High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.
Tarella C; Di Nicola M; Caracciolo D; Zallio F; Cuttica A; Omedè P; Bondesan P; Magni M; Matteucci P; Gallamini A; Pileri A; Gianni AM
Bone Marrow Transplant; 2002 Dec; 30(11):725-32. PubMed ID: 12439694
[TBL] [Abstract][Full Text] [Related]
13. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment.
Bolwell BJ; Fishleder A; Andresen SW; Lichtin AE; Koo A; Yanssens T; Burwell R; Baucco P; Green R
Bone Marrow Transplant; 1993 Dec; 12(6):609-14. PubMed ID: 7511016
[TBL] [Abstract][Full Text] [Related]
14. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
Sinitsyn Y; Malone A; Mandeli J; Grosskreutz C; Osman K; Scigliano E; Shi P; Isola L
Cytotherapy; 2009; 11(4):457-63. PubMed ID: 19499401
[TBL] [Abstract][Full Text] [Related]
15. Chemopurging of peripheral blood-derived progenitor cells by alkyl-lysophospholipid and its effect on haematopoietic rescue after high-dose therapy.
Koenigsmann MP; Notter M; Knauf WU; Papadimitriou CA; Oberberg D; Reufi B; Mücke C; Thiel E; Berdel WE
Bone Marrow Transplant; 1996 Sep; 18(3):549-57. PubMed ID: 8879616
[TBL] [Abstract][Full Text] [Related]
16. Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF.
Ricca I; Compagno M; Ladetto M; Rocci A; Dell'Aquila M; Omedè P; De Marco F; D'Antico S; Caracciolo D; Ferrero D; Carlo-Stella C; Tarella C
Leukemia; 2005 Apr; 19(4):644-51. PubMed ID: 15716989
[TBL] [Abstract][Full Text] [Related]
17. Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support.
Papadopoulos KP; Ayello J; Tugulea S; Heitjan DF; Williams C; Reiss RF; Vahdat LT; Suciu-Foca N; Antman KH; Hesdorffer CS
J Hematother; 1997 Feb; 6(1):61-8. PubMed ID: 9112219
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience.
Lowenthal RM; Fabères C; Marit G; Boiron JM; Cony-Makhoul P; Pigneux A; Agape P; Vezon G; Bouzgarou R; Dazey B; Fizet D; Bernard P; Lacombe F; Reiffers J
Bone Marrow Transplant; 1998 Oct; 22(8):763-70. PubMed ID: 9827973
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
Olivieri A; Offidani M; Montanari M; Ciniero L; Cantori I; Ombrosi L; Masia CM; Centurioni R; Mancini S; Brunori M; Leoni P
Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
[TBL] [Abstract][Full Text] [Related]
20. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D
Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
